Search Details

Word: cancer (lookup in dictionary) (lookup stats)
Dates: during 2000-2009
Sort By: most recent first (reverse)


Usage:

...those tasks, he brought his superabundant energies, look-at-me narcissism and gleefully roguish manner. But in one job, he left the world a changed place. In his 10 years as director of New York's Metropolitan Museum of Art, Hoving, who was 78 when he died of cancer on Dec. 10, didn't just transform the Met. He remade the very idea of museums...

Author: /time Magazine | Title: Thomas Hoving: The Man Who Made the Modern Met | 12/11/2009 | See Source »

...he’s trying to cure cancer. The biochemistry concentrator, who is a student in the secondary field in Health Policy, experiments with using viruses as cancer therapies for his senior thesis...

Author: By Nora A. Tufano, CRIMSON STAFF WRITER | Title: 15 Most Interesting seniors 2010: Nworah B. Ayogu | 12/11/2009 | See Source »

...Prostate-Cancer Screening To screen or not to screen? When it comes to cancer, doctors say early detection is the best defense. But the picture is a little fuzzier when it comes to prostate cancer, which in many cases progresses slowly and may not require aggressive treatment. In March, a 10-year National Cancer Institute study involving more than 76,000 men seemed to make the case for watchful waiting. About half of the study volunteers were randomly assigned to the screening group, getting either a manual exam or a prostate-specific antigen test each year; the latter test measures...

Author: /time Magazine | Title: TIME's Top 10 Medical Breakthroughs of 2009 | 12/8/2009 | See Source »

Based on this and other studies, the U.S. Preventive Services Task Force said there was insufficient evidence to assess the balance of benefits and harms of prostate-cancer screening in men younger than age 75. The task force recommended against prostate-cancer screening in men 75 and older...

Author: /time Magazine | Title: TIME's Top 10 Medical Breakthroughs of 2009 | 12/8/2009 | See Source »

...different way ? by curbing the formation of the bone-gnawing cells. That tilts the balance in favor of bone-building. In two studies published in August, the experimental compound denosumab was shown to reduce the risk of fractures in postmenopausal women as well as men being treated for prostate cancer, the two largest patient populations at risk for bone loss. What's not clear, however, is how the new drug, if approved, would compare with existing osteoporosis drugs like Fosamax, Boniva and Reclast...

Author: /time Magazine | Title: TIME's Top 10 Medical Breakthroughs of 2009 | 12/8/2009 | See Source »

Previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | Next